semaglutide adverse reactions Suboptimal therapeutic responses associated with in type 2 diabetes and obesity: A meta-analysis of randomized controlled trials: Cell Reports Medicine New-side-effect-identified-as-a-common-adverse-reaction-to-GLP-1-drugs

With so many changes affecting the body during menopause, weight gain is a common concern for women around this age

Patient education is essential for appropriate management

Improvements in cardiovascular risk markers including blood pressure, triglycerides, and HbA1c were observed in the Phase 2 trial (Jastreboff et al., NEJM, 2023), all of which are clinically relevant for women, particularly those in midlife and beyond

Informed Consent: To mitigate this, providers must use robust informed consent forms where the patient explicitly acknowledges they are receiving a compounded, non-FDA-approved medication, not the brand-name drug

Yes, for patients with obesity-related sleep disorders such as obstructive sleep apnoea, the weight loss achieved through Wegovy treatment may lead to significant improvements in sleep architecture and overall sleep quality as treatment progresses

Van Immerseel F, Ducatelle R, De Vos M, Boon N, Van De Wiele T, Verbeke K, Rutgeerts P, Sas B, Louis P, Flint HJ